Assetmark, Inc Abcam PLC Transaction History

Assetmark, Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 27, 2023	SELL	$21.54 - $24.41 $12,277 - $13,913	-570 Reduced 25.01%	1,709 $38,000
Q2 2023 Aug 11, 2023	SELL	$12.62 - $24.47 $2,221 - $4,306	-176 Reduced 7.17%	2,279 $55,000
Q1 2023 May 05, 2023	BUY	$12.98 - $17.1 $5,451 - $7,182	420 Added 20.64%	2,455 $33,000
Q4 2022 Feb 10, 2023	BUY	$13.92 - $17.0 $7,308 - $8,925	525 Added 34.77%	2,035 $31,000
Q3 2022 Nov 01, 2022	BUY	$13.36 - $16.75 $5,303 - $6,649	397 Added 35.67%	1,510 $23,000
Q2 2022 Aug 03, 2022	BUY	$12.69 - $19.25 $14,123 - $21,425	1,113 New	1,113 $16,000

1.03M

Ticker ABCM
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 229,044,992
Description
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

Stay updated on Assetmark, Inc with notifications on news.